Skip to main content
SpringerLink
Log in

Nodular lymphocyte-predominant Hodgkin lymphoma

  • Published:
Current Hematologic Malignancy Reports Aims and scope Submit manuscript

Abstract

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma that differs from classic Hodgkin lymphoma (cHL) with respect to histologic and clinical presentation. Because the prognosis of NLPHL in early unfavorable and advanced stages is similar to that of cHL, treatment is similar. In contrast, early favorable-stage NLPHL has a better prognosis than cHL. Thus, NLPHL in early favorable stages might be treated with reduced-intensity programs without compromising cure rates. Because involved-field radiotherapy alone seems to be as effective as extended-field radiotherapy or combined modalities, it has been adopted by the German Hodgkin Study Group and the European Organisation for Research and Treatment of Cancer as the treatment of choice for stage IA NLPHL. Now that efficacy of the monoclonal antibody rituximab has been shown in relapsed NLPHL, its use in the first-line treatment of NLPHL is under investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Jost LM, Stahel RA: ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin’s disease. Ann Oncol 2005, 16(Suppl 1):i54–i55.

    Article  PubMed  Google Scholar 

  2. Ries LA, Kosary CL, Hankey BF, et al.: SEER Cancer Statistics Review: 1973–1994. Bethesda, MD: National Cancer Institute; 1997.

    Google Scholar 

  3. Diehl V, Sextro M, Franklin J, et al.: Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin’s disease and lymphocyte-rich classical Hodgkin’s disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin’s Disease. J Clin Oncol 1999, 17:776–783.

    PubMed  CAS  Google Scholar 

  4. Anagnostopoulos I, Hansmann ML, Franssila K, et al.: European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 2000, 96:1889–1899.

    PubMed  CAS  Google Scholar 

  5. Trudel MA, Krikorian JG, Neiman RS: Lymphocyte predominance Hodgkin’s disease. A clinicopathologic reassessment. Cancer 1987, 59:99–106.

    Article  PubMed  CAS  Google Scholar 

  6. Pappa VI, Norton AJ, Gupta RK, et al.: Nodular type of lymphocyte predominant Hodgkin’s disease. A clinical study of 50 cases. Ann Oncol 1995, 6:559–565.

    PubMed  CAS  Google Scholar 

  7. Nogová L, Reineke T, Eich HT, et al.: Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin’s lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG). Ann Oncol 2005, 16:1683–1687.

    Article  PubMed  Google Scholar 

  8. Ekstrand BC, Lucas JB, Horwitz SM, et al.: Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. Blood 2003, 101:4285–4289.

    Article  PubMed  CAS  Google Scholar 

  9. Pellegrino B, Terrier-Lacombe MJ, Oberlin O, et al.: Lymphocyte-predominant Hodgkin’s lymphoma in children: therapeutic abstention after initial lymph node resection—a Study of the French Society of Pediatric Oncology. J Clin Oncol 2003, 21:2948–2952.

    Article  PubMed  CAS  Google Scholar 

  10. Mauz-Körholz C, Gorde-Grosjean S, Hasenclever D, et al.: Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma. Cancer 2007, 110:179–185.

    Article  PubMed  Google Scholar 

  11. Burns BF, Colby TV, Dorfman RF: Differential diagnostic features of nodular L & H Hodgkin’s disease, including progressive transformation of germinal centers. Am J Surg Pathol 1984, 8:253–261.

    Article  PubMed  CAS  Google Scholar 

  12. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds.: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.

    Google Scholar 

  13. Nicholas DS, Harris S, Wright DH: Lymphocyte predominance Hodgkin’s disease—an immunohistochemical study. Histopathology 1990, 16:157–165.

    PubMed  CAS  Google Scholar 

  14. Bracuninger A, Kuppers R, Strickler JG, et al.: Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A. 1997, 94:9337–9342.

    Article  Google Scholar 

  15. Marafioti T, Pozzobon M, Hansmann ML, et al.: Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood 2004, 103:188–193.

    Article  PubMed  CAS  Google Scholar 

  16. Wickert RS, Weisenburger DD, Tierens A, et al.: Clonal relationship between lymphocytic predominance Hodgkin’s disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood 1995, 86:2312–2320.

    PubMed  CAS  Google Scholar 

  17. Bennett MH, MacLennan KA, Vaughan Hudson G, Vaughan Hudson B: Non-Hodgkin’s lymphoma arising in patients treated for Hodgkin’s disease in the BNLI: a 20-year experience British. National Lymphoma Investigation. Ann Oncol 1991, 2(Suppl 2):83–92.

    PubMed  Google Scholar 

  18. Huang JZ, Weisenburger DD, Vose JM, et al.: Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group. Leuk Lymphoma 2003, 44:1903–1910.

    Article  PubMed  Google Scholar 

  19. Nogová L, Reineke T, Brillant C, et al.: Lymphocyte-predominant and classical Hodgkin’s lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol 2008, 26:434–439.

    Article  PubMed  Google Scholar 

  20. Nogová L, Reineke T, Josting A, et al.: Lymphocyte-predominant and classical Hodgkin’s lymphoma—comparison of outcomes. Eur J Haematol Suppl 2005, Jul:106–110.

  21. Wirth A, Yuen K, Barton M, et al.: Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group. Cancer 2005, 104:1221–1229.

    Article  PubMed  Google Scholar 

  22. Chera BS, Olivier K, Morris CG, et al.: Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida. Am J Clin Oncol 2007, 30:601–606.

    Article  PubMed  Google Scholar 

  23. Schlembach PJ, Wilder RB, Jones D, et al.: Radiotherapy alone for lymphocyte-predominant Hodgkin’s disease. Cancer J 2002, 8:377–383.

    Article  PubMed  Google Scholar 

  24. Raemaekers J, Kluin-Nelemans H, Teodorovic I, et al.: The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer. Eur J Cancer 2002, 38(Suppl 4):S107–S113.

    Article  PubMed  Google Scholar 

  25. Savage KJ, Hoskins P, Klasa R, et al.: ABVD chemotherapy is essential for optimal treatment of limited stage nodular lymphocyte predominant Hodgkin Lymphoma. Haematologica 2007, 92(Suppl 5):C012.

    Google Scholar 

  26. Schulz H, Rehwald U, Morschhauser F, et al.: Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG). Blood 2008, 111:109–111.

    Article  PubMed  CAS  Google Scholar 

  27. Rehwald U, Schulz H, Reiser M, et al.: Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group. Blood 2003, 101:420–424.

    Article  PubMed  CAS  Google Scholar 

  28. Shimabukuro-Vornhagen A, Haverkamp H, Engert A, et al.: Lymphocyte-rich classical Hodgkin’s lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin’s Study Group trials. J Clin Oncol 2005, 23:5739–5745.

    Article  PubMed  Google Scholar 

  29. Feugier P, Labouyrie E, Djeridane M, et al.: Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation. Blood 2004, 104:2675–2681.

    Article  PubMed  CAS  Google Scholar 

  30. Fanale MA, Fayad LE, Romaguera JE, et al.: Experience with R-CHOP in patients with lymphocyte predominant Hodgkin Lymphoma (LPHL). Haematologica 2007, 92(Suppl 5):P077.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, 50924, Cologne, Germany

    Andreas Engert

Authors
  1. Michael Fuchs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dennis A. Eichenauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lucia Nogová
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Volker Diehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas Engert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Engert.

Additional information

for the German Hodgkin Study Group

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fuchs, M., Eichenauer, D.A., Nogová, L. et al. Nodular lymphocyte-predominant Hodgkin lymphoma. Curr Hematol Malig Rep 3, 126–131 (2008). https://doi.org/10.1007/s11899-008-0019-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11899-008-0019-5

Keywords

Search

Navigation